Procter & Gamble to Co-Promote Novartis’ Enablex®

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 62 (Table of Contents)

Published: 5 Aug-2005

DOI: 10.3833/pdr.v2005.i62.645     ISSN: 1756-7874

Section: Distribution & Marketing

Fulltext:

Abstract

Procter & Gamble Pharmaceuticals (P&GP) and Novartis entered into co-promotion agreement for P&GP’s Enablex® (darifenacin)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details